Antiviral therapy

Details for Australian Patent Application No. 2009240021 (hide)

Owner Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute for Biomedical Research University Hospital Basel

Inventors Duong, Francois H.T.; Filipowicz, Witold; Oakeley, Edward; Heim, Markus; Sarasin-Filipowicz, Magdalena

Agent Davies Collison Cave

Pub. Number AU-A-2009240021

PCT Pub. Number WO2009/130176

Priority 08154878.6 21.04.08 EP

Filing date 20 April 2009

Wipo publication date 29 October 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/576 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for hepatitis

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/130176 Priority application(s): WO2009/130176

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009240026-Dry transglutaminase composition

2009240011-Vaccine compositions for the treatment of dengue fever and uses thereof